Syndax Pharmaceuticals
SNDX
#6582
Rank
A$1.18 B
Marketcap
A$13.15
Share price
-4.49%
Change (1 day)
-48.93%
Change (1 year)

Earnings for Syndax Pharmaceuticals (SNDX)

Earnings in 2026 (TTM): -A$0.31 Billion

According to Syndax Pharmaceuticals's latest financial reports the company's current earnings are A$0.28 Billion. In 2025 the company made an earning of -A$0.44 Billion, an increase over its 2024 earnings that were of -A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Syndax Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.31 Billion-28.96%
2025 -A$0.44 Billion-10.46%
2024 -A$0.49 Billion52.25%
2023 -A$0.32 Billion40.19%
2022 -A$0.23 Billion-699.13%
2021 A$37.58 M-134.07%
2020 -A$0.12 Billion30.53%
2019 -A$84.52 Million-24.22%
2018 -A$0.12 Billion21.64%
2017 -A$91.69 Million36.72%
2016 -A$67.07 Million84.39%
2015 -A$36.38 Million21.64%
2014 -A$29.91 Million39.92%
2013 -A$21.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA